Unity Biotechnology Stock Options
| UBX Stock | USD 0.16 0.01 6.67% |
Unity Biotechnology's latest option contracts expiring on August 15th 2025 are carrying combined implied volatility of 3.66 with a put-to-call open interest ratio of 0.09 over 12 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on August 15th 2025.
Open Interest Against August 15th 2025 Option Contracts
Unity Biotechnology option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Unity Biotechnology's lending market. For example, when Unity Biotechnology's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Unity Biotechnology, he or she must hedge the risk by shorting Unity Biotechnology stock over its option's life.
2025-08-15
The chart above shows Unity Biotechnology's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Unity Biotechnology's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Unity Biotechnology's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Unity Biotechnology
Analyzing Unity Biotechnology's in-the-money options over time can help investors to take a profitable long position in Unity Biotechnology regardless of its overall volatility. This is especially true when Unity Biotechnology's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Unity Biotechnology's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Unity Biotechnology's stock while costing only a fraction of its price.
Unity Current Options Market Mood
Unity Biotechnology's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Unity Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Unity Biotechnology's options investors are not very successful. Unity Biotechnology's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Unity contract
Base on the Rule 16, the options market is currently suggesting that Unity Biotechnology will have an average daily up or down price movement of about 0.23% per day over the life of the 2025-08-15 option contract. With Unity Biotechnology trading at USD 0.16, that is roughly USD 3.66E-4. If you think that the market is fully incorporating Unity Biotechnology's daily price movement you should consider buying Unity Biotechnology options at the current volatility level of 3.66%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Unity Biotechnology options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Unity calls. Remember, the seller must deliver Unity Biotechnology stock to the call owner when a call is exercised.
Unity Biotechnology Option Chain
When Unity Biotechnology's strike price is surpassing the current stock price, the option contract against Unity Biotechnology stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Unity Biotechnology's option chain is a display of a range of information that helps investors for ways to trade options on Unity. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Unity. It also shows strike prices and maturity days for a Unity Biotechnology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | UBX250815C00006000 | 0 | 6.0 | 0.0 - 0.75 | 0.75 | |
Call | UBX250815C00005000 | 14 | 5.0 | 0.0 - 5.0 | 5.0 | Out |
Call | UBX250815C00004000 | 129 | 4.0 | 0.0 - 0.75 | 0.75 | Out |
Call | UBX250815C00003000 | 87 | 3.0 | 0.0 - 0.75 | 0.75 | Out |
Call | UBX250815C00002000 | 947 | 2.0 | 0.0 - 0.1 | 0.1 | Out |
Call | UBX250815C00001000 | 178 | 1.0 | 0.0 - 0.05 | 0.04 | Out |
Put | UBX250815P00006000 | 0 | 6.0 | 5.5 - 6.0 | 5.5 | In |
Put | UBX250815P00005000 | 0 | 5.0 | 3.9 - 5.6 | 3.9 | In |
Put | UBX250815P00004000 | 5 | 4.0 | 3.6 - 4.0 | 3.6 | In |
Put | UBX250815P00003000 | 0 | 3.0 | 2.5 - 2.95 | 2.5 | In |
Put | UBX250815P00002000 | 103 | 2.0 | 0.0 - 1.9 | 1.9 | In |
Put | UBX250815P00001000 | 13 | 1.0 | 0.0 - 0.95 | 0.95 | In |
Unity Total Stockholder Equity
Total Stockholder Equity |
|
Unity Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Unity Biotechnology stock to make a market-neutral strategy. Peer analysis of Unity Biotechnology could also be used in its relative valuation, which is a method of valuing Unity Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Unity Biotechnology Corporate Management
| Dr AB | CoFounder Director | Profile | |
| Nathan Guz | Vice Operations | Profile | |
| Judith Campisi | Founder | Profile | |
| Daohong MD | Founder | Profile | |
| Anirvan Ghosh | CEO Director | Profile | |
| Jamie MD | Chief Officer | Profile |
Additional Tools for Unity Stock Analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.